Market Analysis and Insights: Global Connected Injectable Drug Delivery Devices Market
The global Connected Injectable Drug Delivery Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Connected Injectable Drug Delivery Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Connected Injectable Drug Delivery Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Connected Injectable Drug Delivery Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Connected Injectable Drug Delivery Devices market.
Global Connected Injectable Drug Delivery Devices Scope and Market Size
The research report includes specific segments by region (country),
by company,
by Type and
by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Conventional Injection Devices
- Self-Injection Devices
- Others
Segment by Application
- Diabetes
- Cardiovascular Diseases
- Autoimmune Diseases
- Hormones Replacement
- Neurology
- Addiction
- Respiratory Diseases
- Others
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
By Company
- Phillips-Medisize
- West Pharmaceutical Services
- Biocorp
- Aterica
- Unilife
- Propeller Health
- Haselmeier
- SHL
- Becton Dickinson
- Baxter International
- Scandinavian Health
- Ypsomed
- Terumo Medical
- Schott
- Owen Mumford
- Antares Pharma
- Zogenix
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Connected Injectable Drug Delivery Devices product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Connected Injectable Drug Delivery Devices, with price, sales, revenue, and global market share of Connected Injectable Drug Delivery Devices from 2019 to 2022.
Chapter 3, the Connected Injectable Drug Delivery Devices competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Connected Injectable Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Connected Injectable Drug Delivery Devices market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Connected Injectable Drug Delivery Devices.
Chapter 13, 14, and 15, to describe Connected Injectable Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Connected Injectable Drug Delivery Devices Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Connected Injectable Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Connected Injectable Drug Delivery Devices
1.2 Connected Injectable Drug Delivery Devices Segment by Type
1.2.1 Global Connected Injectable Drug Delivery Devices Sales Growth Rate Comparison by Type (2023-2032)
1.2.2 Conventional Injection Devices
1.2.3 Self-Injection Devices
1.2.4 Others
1.3 Connected Injectable Drug Delivery Devices Segment by Application
1.3.1 Global Connected Injectable Drug Delivery Devices Sales Comparison by Application: (2023-2032)
1.3.2 Diabetes
1.3.3 Cardiovascular Diseases
1.3.4 Autoimmune Diseases
1.3.5 Hormones Replacement
1.3.6 Neurology
1.3.7 Addiction
1.3.8 Respiratory Diseases
1.3.9 Others
1.4 Global Connected Injectable Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Connected Injectable Drug Delivery Devices Revenue 2018-2032
1.4.2 Global Connected Injectable Drug Delivery Devices Sales 2018-2032
1.4.3 Connected Injectable Drug Delivery Devices Market Size by Region: 2018 Versus 2022 Versus 2032
2 Connected Injectable Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Connected Injectable Drug Delivery Devices Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Connected Injectable Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Connected Injectable Drug Delivery Devices Market Competitive Situation and Trends
2.5.1 Connected Injectable Drug Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Connected Injectable Drug Delivery Devices Players Market Share by Revenue
2.5.3 Global Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Connected Injectable Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Connected Injectable Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Connected Injectable Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
3.3.1 North America Connected Injectable Drug Delivery Devices Sales by Country
3.3.2 North America Connected Injectable Drug Delivery Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Connected Injectable Drug Delivery Devices Sales by Country
3.4.2 Europe Connected Injectable Drug Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Connected Injectable Drug Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region
3.5.2 Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Connected Injectable Drug Delivery Devices Sales by Country
3.6.2 Latin America Connected Injectable Drug Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country
3.7.2 Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Connected Injectable Drug Delivery Devices Historic Market Analysis by Type
4.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2018-2023)
4.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2018-2023)
4.3 Global Connected Injectable Drug Delivery Devices Price by Type (2018-2023)
5 Global Connected Injectable Drug Delivery Devices Historic Market Analysis by Application
5.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2018-2023)
5.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2018-2023)
5.3 Global Connected Injectable Drug Delivery Devices Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Phillips-Medisize
6.1.1 Phillips-Medisize Corporation Information
6.1.2 Phillips-Medisize Description and Business Overview
6.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Product Portfolio
6.1.5 Phillips-Medisize Recent Developments/Updates
6.2 West Pharmaceutical Services
6.2.1 West Pharmaceutical Services Corporation Information
6.2.2 West Pharmaceutical Services Description and Business Overview
6.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product Portfolio
6.2.5 West Pharmaceutical Services Recent Developments/Updates
6.3 Biocorp
6.3.1 Biocorp Corporation Information
6.3.2 Biocorp Description and Business Overview
6.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biocorp Connected Injectable Drug Delivery Devices Product Portfolio
6.3.5 Biocorp Recent Developments/Updates
6.4 Aterica
6.4.1 Aterica Corporation Information
6.4.2 Aterica Description and Business Overview
6.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aterica Connected Injectable Drug Delivery Devices Product Portfolio
6.4.5 Aterica Recent Developments/Updates
6.5 Unilife
6.5.1 Unilife Corporation Information
6.5.2 Unilife Description and Business Overview
6.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Unilife Connected Injectable Drug Delivery Devices Product Portfolio
6.5.5 Unilife Recent Developments/Updates
6.6 Propeller Health
6.6.1 Propeller Health Corporation Information
6.6.2 Propeller Health Description and Business Overview
6.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Propeller Health Connected Injectable Drug Delivery Devices Product Portfolio
6.6.5 Propeller Health Recent Developments/Updates
6.7 Haselmeier
6.6.1 Haselmeier Corporation Information
6.6.2 Haselmeier Description and Business Overview
6.6.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Haselmeier Connected Injectable Drug Delivery Devices Product Portfolio
6.7.5 Haselmeier Recent Developments/Updates
6.8 SHL
6.8.1 SHL Corporation Information
6.8.2 SHL Description and Business Overview
6.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 SHL Connected Injectable Drug Delivery Devices Product Portfolio
6.8.5 SHL Recent Developments/Updates
6.9 Becton Dickinson
6.9.1 Becton Dickinson Corporation Information
6.9.2 Becton Dickinson Description and Business Overview
6.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Product Portfolio
6.9.5 Becton Dickinson Recent Developments/Updates
6.10 Baxter International
6.10.1 Baxter International Corporation Information
6.10.2 Baxter International Description and Business Overview
6.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Baxter International Connected Injectable Drug Delivery Devices Product Portfolio
6.10.5 Baxter International Recent Developments/Updates
6.11 Scandinavian Health
6.11.1 Scandinavian Health Corporation Information
6.11.2 Scandinavian Health Connected Injectable Drug Delivery Devices Description and Business Overview
6.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Scandinavian Health Connected Injectable Drug Delivery Devices Product Portfolio
6.11.5 Scandinavian Health Recent Developments/Updates
6.12 Ypsomed
6.12.1 Ypsomed Corporation Information
6.12.2 Ypsomed Connected Injectable Drug Delivery Devices Description and Business Overview
6.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ypsomed Connected Injectable Drug Delivery Devices Product Portfolio
6.12.5 Ypsomed Recent Developments/Updates
6.13 Terumo Medical
6.13.1 Terumo Medical Corporation Information
6.13.2 Terumo Medical Connected Injectable Drug Delivery Devices Description and Business Overview
6.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Terumo Medical Connected Injectable Drug Delivery Devices Product Portfolio
6.13.5 Terumo Medical Recent Developments/Updates
6.14 Schott
6.14.1 Schott Corporation Information
6.14.2 Schott Connected Injectable Drug Delivery Devices Description and Business Overview
6.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Schott Connected Injectable Drug Delivery Devices Product Portfolio
6.14.5 Schott Recent Developments/Updates
6.15 Owen Mumford
6.15.1 Owen Mumford Corporation Information
6.15.2 Owen Mumford Connected Injectable Drug Delivery Devices Description and Business Overview
6.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Owen Mumford Connected Injectable Drug Delivery Devices Product Portfolio
6.15.5 Owen Mumford Recent Developments/Updates
6.16 Antares Pharma
6.16.1 Antares Pharma Corporation Information
6.16.2 Antares Pharma Connected Injectable Drug Delivery Devices Description and Business Overview
6.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Antares Pharma Connected Injectable Drug Delivery Devices Product Portfolio
6.16.5 Antares Pharma Recent Developments/Updates
6.17 Zogenix
6.17.1 Zogenix Corporation Information
6.17.2 Zogenix Connected Injectable Drug Delivery Devices Description and Business Overview
6.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Zogenix Connected Injectable Drug Delivery Devices Product Portfolio
6.17.5 Zogenix Recent Developments/Updates
7 Connected Injectable Drug Delivery Devices Manufacturing Cost Analysis
7.1 Connected Injectable Drug Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
7.4 Connected Injectable Drug Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Connected Injectable Drug Delivery Devices Distributors List
8.3 Connected Injectable Drug Delivery Devices Customers
9 Connected Injectable Drug Delivery Devices Market Dynamics
9.1 Connected Injectable Drug Delivery Devices Industry Trends
9.2 Connected Injectable Drug Delivery Devices Market Drivers
9.3 Connected Injectable Drug Delivery Devices Market Challenges
9.4 Connected Injectable Drug Delivery Devices Market Restraints
10 Global Market Forecast
10.1 Connected Injectable Drug Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Connected Injectable Drug Delivery Devices by Type (2023-2032)
10.1.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Type (2023-2032)
10.2 Connected Injectable Drug Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Connected Injectable Drug Delivery Devices by Application (2023-2032)
10.2.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Application (2023-2032)
10.3 Connected Injectable Drug Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Connected Injectable Drug Delivery Devices by Region (2023-2032)
10.3.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Region (2023-2032)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Connected Injectable Drug Delivery Devices Sales Growth Rate Comparison by Type (2023-2032) & (K Units) & (US$ Million)
Table 2. Global Connected Injectable Drug Delivery Devices Sales Growth Rate Comparison by Application (2023-2032) & (K Units) & (US$ Million)
Table 3. Global Connected Injectable Drug Delivery Devices Market Size by Region (US$ Million) (2018 VS 2022 VS 2032)
Table 4. Global Connected Injectable Drug Delivery Devices Market Competitive Situation by Manufacturers in 2022
Table 5. Global Connected Injectable Drug Delivery Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Connected Injectable Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Connected Injectable Drug Delivery Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Connected Injectable Drug Delivery Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Connected Injectable Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Connected Injectable Drug Delivery Devices as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Connected Injectable Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 16. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2018-2023)
Table 17. Global Connected Injectable Drug Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Table 19. North America Connected Injectable Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 20. North America Connected Injectable Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 21. North America Connected Injectable Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 23. Europe Connected Injectable Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 24. Europe Connected Injectable Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 25. Europe Connected Injectable Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Connected Injectable Drug Delivery Devices Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Table 31. Latin America Connected Injectable Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Connected Injectable Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 33. Latin America Connected Injectable Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Connected Injectable Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 39. Global Connected Injectable Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 40. Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2018-2023)
Table 41. Global Connected Injectable Drug Delivery Devices Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Connected Injectable Drug Delivery Devices Revenue Share by Type (2018-2023)
Table 43. Global Connected Injectable Drug Delivery Devices Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Connected Injectable Drug Delivery Devices Sales (K Units) by Application (2018-2023)
Table 45. Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2018-2023)
Table 46. Global Connected Injectable Drug Delivery Devices Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Connected Injectable Drug Delivery Devices Revenue Share by Application (2018-2023)
Table 48. Global Connected Injectable Drug Delivery Devices Price by Application (2018-2023) & (USD/Unit)
Table 49. Phillips-Medisize Corporation Information
Table 50. Phillips-Medisize Description and Business Overview
Table 51. Phillips-Medisize Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Phillips-Medisize Connected Injectable Drug Delivery Devices Product
Table 53. Phillips-Medisize Recent Developments/Updates
Table 54. West Pharmaceutical Services Corporation Information
Table 55. West Pharmaceutical Services Description and Business Overview
Table 56. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product
Table 58. West Pharmaceutical Services Recent Developments/Updates
Table 59. Biocorp Corporation Information
Table 60. Biocorp Description and Business Overview
Table 61. Biocorp Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Biocorp Connected Injectable Drug Delivery Devices Product
Table 63. Biocorp Recent Developments/Updates
Table 64. Aterica Corporation Information
Table 65. Aterica Description and Business Overview
Table 66. Aterica Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Aterica Connected Injectable Drug Delivery Devices Product
Table 68. Aterica Recent Developments/Updates
Table 69. Unilife Corporation Information
Table 70. Unilife Description and Business Overview
Table 71. Unilife Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Unilife Connected Injectable Drug Delivery Devices Product
Table 73. Unilife Recent Developments/Updates
Table 74. Propeller Health Corporation Information
Table 75. Propeller Health Description and Business Overview
Table 76. Propeller Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Propeller Health Connected Injectable Drug Delivery Devices Product
Table 78. Propeller Health Recent Developments/Updates
Table 79. Haselmeier Corporation Information
Table 80. Haselmeier Description and Business Overview
Table 81. Haselmeier Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Haselmeier Connected Injectable Drug Delivery Devices Product
Table 83. Haselmeier Recent Developments/Updates
Table 84. SHL Corporation Information
Table 85. SHL Description and Business Overview
Table 86. SHL Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. SHL Connected Injectable Drug Delivery Devices Product
Table 88. SHL Recent Developments/Updates
Table 89. Becton Dickinson Corporation Information
Table 90. Becton Dickinson Description and Business Overview
Table 91. Becton Dickinson Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Becton Dickinson Connected Injectable Drug Delivery Devices Product
Table 93. Becton Dickinson Recent Developments/Updates
Table 94. Baxter International Corporation Information
Table 95. Baxter International Description and Business Overview
Table 96. Baxter International Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Baxter International Connected Injectable Drug Delivery Devices Product
Table 98. Baxter International Recent Developments/Updates
Table 99. Scandinavian Health Corporation Information
Table 100. Scandinavian Health Description and Business Overview
Table 101. Scandinavian Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Scandinavian Health Connected Injectable Drug Delivery Devices Product
Table 103. Scandinavian Health Recent Developments/Updates
Table 104. Ypsomed Corporation Information
Table 105. Ypsomed Description and Business Overview
Table 106. Ypsomed Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Ypsomed Connected Injectable Drug Delivery Devices Product
Table 108. Ypsomed Recent Developments/Updates
Table 109. Terumo Medical Corporation Information
Table 110. Terumo Medical Description and Business Overview
Table 111. Terumo Medical Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Terumo Medical Connected Injectable Drug Delivery Devices Product
Table 113. Terumo Medical Recent Developments/Updates
Table 114. Schott Corporation Information
Table 115. Schott Description and Business Overview
Table 116. Schott Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Schott Connected Injectable Drug Delivery Devices Product
Table 118. Schott Recent Developments/Updates
Table 119. Owen Mumford Corporation Information
Table 120. Owen Mumford Description and Business Overview
Table 121. Owen Mumford Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Owen Mumford Connected Injectable Drug Delivery Devices Product
Table 123. Owen Mumford Recent Developments/Updates
Table 124. Antares Pharma Corporation Information
Table 125. Antares Pharma Description and Business Overview
Table 126. Antares Pharma Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Antares Pharma Connected Injectable Drug Delivery Devices Product
Table 128. Antares Pharma Recent Developments/Updates
Table 129. Zogenix Corporation Information
Table 130. Zogenix Description and Business Overview
Table 131. Zogenix Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Zogenix Connected Injectable Drug Delivery Devices Product
Table 133. Zogenix Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Connected Injectable Drug Delivery Devices Distributors List
Table 137. Connected Injectable Drug Delivery Devices Customers List
Table 138. Connected Injectable Drug Delivery Devices Market Trends
Table 139. Connected Injectable Drug Delivery Devices Market Drivers
Table 140. Connected Injectable Drug Delivery Devices Market Challenges
Table 141. Connected Injectable Drug Delivery Devices Market Restraints
Table 142. Global Connected Injectable Drug Delivery Devices Sales Forecast by Type (2023-2032) & (K Units)
Table 143. Global Connected Injectable Drug Delivery Devices Sales Market Share Forecast by Type (2023-2032)
Table 144. Global Connected Injectable Drug Delivery Devices Revenue Forecast by Type (2023-2032) & (US$ Million)
Table 145. Global Connected Injectable Drug Delivery Devices Revenue Market Share Forecast by Type (2023-2032)
Table 146. Global Connected Injectable Drug Delivery Devices Sales Forecast by Application (2023-2032) & (K Units)
Table 147. Global Connected Injectable Drug Delivery Devices Sales Market Share Forecast by Application (2023-2032)
Table 148. Global Connected Injectable Drug Delivery Devices Revenue Forecast by Application (2023-2032) & (US$ Million)
Table 149. Global Connected Injectable Drug Delivery Devices Revenue Market Share Forecast by Application (2023-2032)
Table 150. Global Connected Injectable Drug Delivery Devices Sales Forecast by Region (2023-2032) & (K Units)
Table 151. Global Connected Injectable Drug Delivery Devices Sales Market Share Forecast by Region (2023-2032)
Table 152. Global Connected Injectable Drug Delivery Devices Revenue Forecast by Region (2023-2032) & (US$ Million)
Table 153. Global Connected Injectable Drug Delivery Devices Revenue Market Share Forecast by Region (2023-2032)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Connected Injectable Drug Delivery Devices
Figure 2. Global Connected Injectable Drug Delivery Devices Market Share by Type in 2022 & 2032
Figure 3. Conventional Injection Devices Product Picture
Figure 4. Self-Injection Devices Product Picture
Figure 5. Others Product Picture
Figure 6. Global Connected Injectable Drug Delivery Devices Market Share by Application in 2022 & 2032
Figure 7. Diabetes
Figure 8. Cardiovascular Diseases
Figure 9. Autoimmune Diseases
Figure 10. Hormones Replacement
Figure 11. Neurology
Figure 12. Addiction
Figure 13. Respiratory Diseases
Figure 14. Others
Figure 15. Global Connected Injectable Drug Delivery Devices Revenue, (US$ Million), 2018 VS 2022 VS 2032
Figure 16. Global Connected Injectable Drug Delivery Devices Market Size (2018-2032) & (US$ Million)
Figure 17. Global Connected Injectable Drug Delivery Devices Sales (2018-2032) & (K Units)
Figure 18. Connected Injectable Drug Delivery Devices Sales Share by Manufacturers in 2022
Figure 19. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Connected Injectable Drug Delivery Devices Players: Market Share by Revenue in 2022
Figure 21. Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2018-2023)
Figure 23. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region in 2022
Figure 24. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Figure 25. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region in 2022
Figure 26. U.S. Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Canada Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Germany Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. France Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. U.K. Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Italy Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Russia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. China Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Japan Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. South Korea Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. India Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Australia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Taiwan Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Indonesia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Thailand Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Malaysia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Philippines Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Vietnam Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Mexico Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Brazil Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Argentina Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. Turkey Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. Saudi Arabia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 49. UAE Connected Injectable Drug Delivery Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 50. Sales Market Share of Connected Injectable Drug Delivery Devices by Type (2018-2023)
Figure 51. Manufacturing Cost Structure of Connected Injectable Drug Delivery Devices
Figure 52. Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
Figure 53. Connected Injectable Drug Delivery Devices Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
